Scilex Holding Company

SCLX

Equity

ISIN null / Valor 123144552

NASDAQ (2025-11-19)

USD 17.18+4.95%

Scilex Holding Company
UMushroom community rating:

4.52 7 votes No rating yet

NegativeNeutralPositive

About company

Scilex Holding Company, listed on Nasdaq as SCLX, is a revenue-generating company that specializes in acquiring, developing, and commercializing non-opioid pain management products for both acute and chronic pain. The company aims to establish itself as a global leader in pain management while adhering to social, environmental, economic, and ethical principles in the development of pharmaceutical products that enhance the quality of life. Scilex Holding Company owns subsidiaries such as Scilex Pharmaceuticals and Semnur Pharmaceuticals, which are integral to its operations in the pharmaceutical industry.

Summarized from source with an LLMView SourceSector: Healthcare

ZTlido Net Sales Increase

ZTlido net sales for the quarter ended September 30, 2024, ranged from $11.0 million to $13.0 million, up from $10.1 million in the same period last year. This represents a growth of approximately 9% to 29% year-over-year.

Total Product Net Sales Growth

Total product net sales for the quarter ended September 30, 2024, were between $12.0 million and $14.0 million, compared to $10.1 million for the same period last year. This marks a substantial growth of approximately 19% to 39% year-over-year.

Summarized from source with an LLMView Source

Key figures

-24.6%1Y

-91.1%3Y

%5Y

Performance

129%1Y

137%3Y

137%5Y

Volatility